However, the current glycan-array technology is limited by the difficulty in producing derivatives of free, reducing glycans with primary amines for conjugation. Now, though, in Nature Methods ...

This unique modality, consisting of synthetic glycans and a proprietary development platform, enables drug discovery research and clinical translation at unprecedented speed. Gut microorganisms ...

The S3 is ideal for DNA production, cell transfection arrays, protein and glycan arrays, and for loading biosensor surfaces or MALDI-MS targets. While being developed for academic budgets ...